Orthotopic PDAC growth is regulated by B cells and FcRγ-positive myeloid cells. Orthotopic PDAC growth is regulated by B cells and FcRγ-positive myeloid.

Slides:



Advertisements
Similar presentations
Supplemental Fig 1 Rt. Lung Tumor A B Murine lung cancer model. LLC were implanted as described in Fig 1. A) Representative histology showing the distribution.
Advertisements

AF647-RIS is internalized by TAMs in vivo.
by Norman Nausch, Ioanna E
Attenuated MDSC-suppressive activity and metastasis development in IDO-deficient mice is rescued by IL-6. Attenuated MDSC-suppressive activity and metastasis.
Sunitinib plus rMVA–CEA–TRICOM vaccine decreased tumor burden and increased intratumoral infiltration of T lymphocytes in the MC38-CEA colon carcinoma.
Combined PLX3397 and PTX treatment inhibits metastasis in a CD8-dependent manner. Combined PLX3397 and PTX treatment inhibits metastasis in a CD8-dependent.
CD1dhiCD5+ B cells are expanded in pancreatic neoplasia and are functionally important for sustaining growth of KrasG12D-PDEC in vivo. CD1dhiCD5+ B cells.
Cytotoxic therapy induces macrophage recruitment, as well as CSF1 and IL-34 mRNA expression. Cytotoxic therapy induces macrophage recruitment, as well.
Volume 20, Issue 3, Pages (July 2017)
Fig. 8. mRIPO elicits neutrophil influx followed by DC and T cell infiltration into tumors. mRIPO elicits neutrophil influx followed by DC and T cell infiltration.
Depletion of T cells, in particular CD8+ T cells, significantly abrogates HEV neogenesis in tumors. Depletion of T cells, in particular CD8+ T cells, significantly.
HIF-1α is critically involved in hypoxia-induced CD137 upregulation.
Cytotoxic therapy induces CSF1-dependent macrophage recruitment.
Volume 16, Issue 3, Pages (September 2009)
Fig. 5 Local gel scaffold for T cell memory response.
LV activation of DCs and subsequent CD8+ T cell priming are dependent on STING and cGAS but not on MyD88, TRIF, or MAVS. LV activation of DCs and subsequent.
Leukocytes in human PDAC
KRAS-induced chemoattractants mediate attraction of macrophages.
TANs mediate obesity-induced tumor progression and aggravated desmoplasia. TANs mediate obesity-induced tumor progression and aggravated desmoplasia. A,
Interleukin-18 and the Costimulatory Molecule B7-1 Have a Synergistic Anti-Tumor Effect on Murine Melanoma; Implication of Combined Immunotherapy for.
Molecular Therapy - Nucleic Acids
Deletion of Crebbp in the GC cooperates with BCL2 deregulation to promote lymphomagenesis. Deletion of Crebbp in the GC cooperates with BCL2 deregulation.
Increase in beige/brown adipocyte characteristics in the xenografts from additional breast cancer cell lines. Increase in beige/brown adipocyte characteristics.
Epithelial loss of TβRII results in increased Th17 cell development.
Fig. 4. Dabrafenib and trametinib changed the cellular components of the tumor microenvironment. Dabrafenib and trametinib changed the cellular components.
Pharmacologic inhibitors of PI3Kγ suppress PDAC growth and metastasis.
B cells infiltrate mouse and human pancreatic neoplasia and promote growth of KrasG12D-PDEC in vivo. B cells infiltrate mouse and human pancreatic neoplasia.
PD-1–PD-L1 axis is highly expressed and is not IFNγ-dependent in a subcutaneous murine model of PDA. A, experimental design for establishment of subcutaneous.
Elevated androgens in global ERα−/− mice decrease lung ILC2 numbers and diminish the KLRG1− ILC2 subset. Elevated androgens in global ERα−/− mice decrease.
Javed Mohammed, Andrew Ryscavage, Rolando Perez-Lorenzo, Andrew J
Volume 17, Issue 4, Pages (October 2015)
Cellular analysis of Epo transgenic mice.
IL-10R-deficient macrophages secrete IL-23, inducing IL-22 secretion by ILC3 and TH17 cells. IL-10R-deficient macrophages secrete IL-23, inducing IL-22.
Socs1 KD tumors exhibit a more T-cell–inflamed phenotype and increased T-cell activation. Socs1 KD tumors exhibit a more T-cell–inflamed phenotype and.
Socs1 KD tumors exhibit a more T cell–inflamed phenotype and increased CD8+ T cell activation. Socs1 KD tumors exhibit a more T cell–inflamed phenotype.
Expression of p110γ isoform in macrophages promotes tumor growth and angiogenesis. Expression of p110γ isoform in macrophages promotes tumor growth and.
PTX in combination with PLX397 induces antitumor T-cell response.
Comparison of the percentages of ducts in the pancreas containing cells showing positive staining for the different markers between control hamster Ig–and.
L-ICON1 is effective for the treatment of murine TNBC (4T1/Luc + GFP) in an orthotopic CDX model. L-ICON1 is effective for the treatment of murine TNBC.
Comparison of the percentages of ducts in the pancreas containing cells showing positive staining for the different markers between control patients and.
The contributions of anti-Ad antibody and T-cell responses to viral clearance in tumor and antitumor efficacy of Ad5 therapy. The contributions of anti-Ad.
Increased CCL5 expression, infiltration of Treg cells, and apoptosis of CD8+ T cells in human colorectal tissues. Increased CCL5 expression, infiltration.
Conversion of CD11bhighCD27high NK cells into MDSCs leads to CD11bhighCD27high and CD11bhighCD27low NK cell reduction. Conversion of CD11bhighCD27high.
CD49b+ cells from tumor-bearing mice are more prone to conversion into MDSCs compared with naive CD49b+ cells. CD49b+ cells from tumor-bearing mice are.
The antitumor and antimetastatic properties of PF in the MX1 orthotopic model. The antitumor and antimetastatic properties of PF in the.
Endothelial cells/microvasucles are increased in prostate cancer versus normal tissues. Endothelial cells/microvasucles are increased in prostate cancer.
CD4+ and CD8+ TILs express surface CD137.
Presence of TNF and ECM degradation are consequences of abundance of macrophages in regions of ADM. A, pancreata of p48Cre;LSL-KrasG12D treated with PBS.
M-CSFR inhibition decreases tumor-associated macrophages in mesothelioma and improves the DC therapy induced CD8+ T-cell phenotype. M-CSFR inhibition decreases.
FcRγ signaling regulates BTK activation and mediates PDAC growth.
BTK-activated signaling regulates PDAC tumorigenesis.
NT157 treatment inhibits LNCaP xenograft growth and delays castration-resistant progression. NT157 treatment inhibits LNCaP xenograft growth and delays.
Tumor cell clusters with increased tumorigenesis, metastasis, and CD44 expression. Tumor cell clusters with increased tumorigenesis, metastasis, and CD44.
CD44 depletion blocks tumor cell aggregation and lung metastasis in vivo. CD44 depletion blocks tumor cell aggregation and lung metastasis in vivo. A,
Immunophenotypic analysis of TILs in B16 and K1735 melanoma following combination therapy with antibodies targeting PS and PD-1. Immunophenotypic analysis.
Anti-SEMA4D antibody regulates immune-cell infiltration and inhibits growth of Tubo.A5 orthotopic mammary carcinoma. Anti-SEMA4D antibody regulates immune-cell.
Tumorigenicity of GR CAFs
Combination of R848 and anti-CD200R affects activation of tumor-infiltrating myeloid cells. Combination of R848 and anti-CD200R affects activation of tumor-infiltrating.
Efficacy of KM100 and/or MTX in BALB/c mice bearing subcutaneous TUBO tumors. Efficacy of KM100 and/or MTX in BALB/c mice bearing subcutaneous TUBO tumors.
The effect of TGFβ on the post-RT increase of Tregs in tumors.
IL35 regulation of tumor growth is accompanied by suppression of CD4+ effector T-cell activity and expansion of Tregs. IL35 regulation of tumor growth.
GCS-100 selectively kills KRAS-addicted lung tumors.
Moderate-affinity vaccine antigens elicited greatest antitumor response. Moderate-affinity vaccine antigens elicited greatest antitumor response. Wild-type.
Identification of a subpopulation of highly metastatic pancreatic cancer cells. Identification of a subpopulation of highly metastatic pancreatic cancer.
In vivo inhibition of IL-17 abrogates tumor-promoting effect of myeloid cells. In vivo inhibition of IL-17 abrogates tumor-promoting effect of myeloid.
Depletion of CD8+, CD4+, and Ly6G+ cells in subcutaneous TUBO tumor-bearing BALB/c mice treated with KM100 + MTX. Depletions were conducted by intraperitoneal.
Volume 12, Issue 12, Pages (September 2015)
CD38 regulates tumor growth and metastasis by adenosine-mediated CD8+ T-cell suppression. CD38 regulates tumor growth and metastasis by adenosine-mediated.
PD-L1 expression is not associated with PTEN expression status in melanomas. PD-L1 expression is not associated with PTEN expression status in melanomas.
Parthenolide inhibits tumor promotion and increases p21 expression in vivo. Parthenolide inhibits tumor promotion and increases p21 expression in vivo.
Presentation transcript:

Orthotopic PDAC growth is regulated by B cells and FcRγ-positive myeloid cells. Orthotopic PDAC growth is regulated by B cells and FcRγ-positive myeloid cells. A, murine PDAC cell lines, derived from Pdx-Cre; LSL-KrasG12D mice harboring an Ink4a/Arfflox/+ allele (Ink4 2.2) or a p53flox/+ allele (p53 2.1.1), were injected orthotopically into the pancreas, and subsequent tumors evaluated by FACS for CD45-positive cellular infiltrates. Graph shows the percentage of CD45+ cells as a percentage of viable cells. B, representative CD19+MHCII+ FACS plot gated on viable CD45+ cells from tumor-naïve pancreas and Ink4 2.2-implanted PDAC tumors in syngeneic JH+/− and JH−/− mice evaluated 28 days after implantation. C, Ink4 2.2 and p53 2.1.1–derived PDACs were quantitatively evaluated in syngeneic JH+/− and JH−/− mice for tumor area in serial H&E-stained tissue sections reflecting tumors isolated on days 14, 21, and 28 after implantation. On right, representative photomicrographs reflecting immunodetection of αSMA in end-stage Ink4 2.2 and p53 2.1.1–derived orthotopic PDAC tumors. D, Ink4 2.2 and p53 2.1.1–derived PDACs were quantitatively evaluated in syngeneic FcRγ+/− and FcRγ−/− mice for tumor area in serial H&E-stained tissue sections reflecting tumors isolated on days 14, 21, and 28 after implantation. Right, representative photomicrographs reflecting immunodetection of αSMA in end-stage Ink4 2.2 and p53 2.1.1–derived orthotopic PDAC tumors. E, qRT-PCR analysis from cDNA reflecting FACS-purified macrophages (MØ = CD45+CD11b+MHCII+F4/80+Ly6C−) or DC (CD45+CD11b+MHCII+F4/80−CD11c+) from Ink4 2.2 PDAC–derived tumors harvested from day 21 FcRγ+/− (n = 10) or FcRγ−/− (n = 8) mice. Displayed are fold changes in genes that reached statistically significant differences. Data are compiled from two independent experiments. For graphs in A, C–E, statistical means are shown, with P values determined by either Student t test or one-way ANOVA when analyzing more than two groups, with *, P < 0.05; **, P < 0. 0.01; ***, P < 0.001. For graphs in C and D, each data point reflects mean tumor size from one mouse based on quantitative morphometry of 5 FFPE sections, resulting from 3 independent experiments. Andrew J. Gunderson et al. Cancer Discov 2016;6:270-285 ©2016 by American Association for Cancer Research